ANTIGEN-ANTIBODY COMPLEXES IN BREAST CANCER
ANTIGEN-ANTIBODY COMPLEXES IN BREAST CANCER
批准号:
3166984
负责人:
Tsann Ming Chu
金额:
$9.54万
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-05-01 至 1986-07-31
关键词:
antibody specificity body fluids breast neoplasms cell mediated cytotoxicity chromatography computer data analysis human subject human therapy evaluation immune complex immunochemistry neoplasm /cancer epidemiology neoplasm /cancer immunodiagnosis neoplasm /cancer relapse /recurrence radioimmunoassay tumor antigens
中文摘要
本研究的目的是测定可溶性抗原抗体复合物在
英文摘要
The objective of this study is to assay soluble antigen-antibody complexes in
serum of patients with breast cancer using C1q binding radioimmunoassay, Raji
cell radioimmunoassay, and (rabbit) rheumatoid factor assay. The serum
specimens will be obtained from breast cancer patients, fibrocystic breast
disease patients and breast cancer families as well as from appropriate healthy
control individuals. The breast cancer patients will be longitudinally followed
for evaluation of the response to treatment in order to determine the prognostic
and monitoring values of the assay. The high risk groups (fibrocystic breast
disease and breast cancer families) are also to be followed in order to evaluate
the diagnostic potential of the immune complex assay. The antigen-antibody
complexes are also to be isolated from the serum and body fluids (pleural
effusion) of breast cancer patients by molecular exclusion chromatography,
protein A affinity chromatography and immunoadsorption using affinity media to
the Fc domain of IgG. Further, the isolated immune complexes will be
dissociated under the least denaturing conditions. The dissociated antigens are
to be characterized biochemically and immunologically. Xenobiotic antisera will
be raised with the dissociated antigen(s) and with isolated complexes as well as
with the Raji cells containing surface-bound immune complexes injected into
rabbits made tolerant to human IgG, and studied by their ability to recombine
the dissociated antigen and to bind malignant breast tissues. In vitro
antibody-dependent cell-mediated cytotoxicity, lymphocyte mitogenesis,
PHA-induced lymphocyte blastogenesis and LAI assays are also to be performed to
study the possible biological function of antibody-antigen complexes. Further,
a radioimmunoassay will be developed which may be of use in early detection and
monitoring of efficacy of therapy for breast cancer.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Experimental tumoricidal effects of monoclonal antibody against solid breast tumors.
单克隆抗体对实体乳腺肿瘤的实验性杀瘤作用。
DOI:
10.1073/pnas.80.23.7328
发表时间:
1983
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[Capone,PM, Papsidero,LD, Croghan,GA, Chu,TM]
通讯作者:
Chu,TM
Relationship between antigen density and immunotherapeutic response elicited by monoclonal antibodies against solid tumors.
抗原密度与针对实体瘤的单克隆抗体引起的免疫治疗反应之间的关系。
DOI:
--
发表时间:
1984
期刊:
Journal of the National Cancer Institute
影响因子:
--
作者:
[Capone,PM, Papsidero,LD, Chu,TM]
通讯作者:
Chu,TM
Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma.
针对人乳腺癌的单克隆抗体(F36/22 和 M7/105)。
DOI:
--
发表时间:
1983
期刊:
Cancer research
影响因子:
11.2
作者:
[Papsidero,LD, Croghan,GA, O'Connell,MJ, Valenzuela,LA, Nemoto,T, Chu,TM]
通讯作者:
Chu,TM
Hybridoma antibody to breast cancer immune complexes.
乳腺癌免疫复合物的杂交瘤抗体。
DOI:
10.1089/hyb.1.1982.1.275
发表时间:
1982
期刊:
Hybridoma
影响因子:
--
作者:
[Papsidero,LD, Nemoto,T, Valenzuela,L, Chu,TM]
通讯作者:
Chu,TM
Potential applications of monoclonal antibodies in cancer diagnosis and therapy.
单克隆抗体在癌症诊断和治疗中的潜在应用。
DOI:
10.3109/07357908509039818
发表时间:
1985
期刊:
Cancer investigation
影响因子:
2.4
作者:
[Chu,TM]
通讯作者:
Chu,TM
共 11 条
TARGETING AND THERAPY OF TUMORS WITH MONOCLONAL ANTIBODY
-
批准号:3175435
-
项目类别:
-
资助金额:$11.26万
-
财政年份:1984
-
负责人:Tsann Ming Chu
-
依托单位:
TARGETING AND THERAPY OF TUMORS WITH MONOCLONAL ANTIBODY
-
批准号:3175437
-
项目类别:
-
资助金额:$10.08万
-
财政年份:1984
-
负责人:Tsann Ming Chu
-
依托单位:
TARGETING AND THERAPY OF TUMORS WITH MONOCLONAL ANTIBODY
-
批准号:3175434
-
项目类别:
-
资助金额:$10.98万
-
财政年份:1984
-
负责人:Tsann Ming Chu
-
依托单位:
TARGETING AND THERAPY OF TUMORS WITH MONOCLONAL ANTIBODY
-
批准号:3175432
-
项目类别:
-
资助金额:$21.41万
-
财政年份:1984
-
负责人:Tsann Ming Chu
-
依托单位:
TARGETING AND THERAPY OF TUMORS WITH MONOCLONAL ANTIBODY
-
批准号:3175436
-
项目类别:
-
资助金额:$14.17万
-
财政年份:1984
-
负责人:Tsann Ming Chu
-
依托单位:
BREAST CARCINOMA ANTIGENS F36/22 AND M7/105
-
批准号:3172050
-
项目类别:
-
资助金额:$9.79万
-
财政年份:1983
-
负责人:Tsann Ming Chu
-
依托单位:
BIOLOGICAL MARKERS IN TREATMENT OF PROSTATE CANCER
-
批准号:3556295
-
项目类别:
-
资助金额:$6.54万
-
财政年份:1979
-
负责人:Tsann Ming Chu
-
依托单位:
ANTIGEN MARKERS IN DIAGNOSIS OF PROSTATE CANCER
-
批准号:3164177
-
项目类别:
-
资助金额:$10.01万
-
财政年份:1976
-
负责人:Tsann Ming Chu
-
依托单位:
海外基金